MECHANISMS OF GLP-1 RECEPTOR AGONISTS IN HFPEF: EXPLORING WEIGHT-DEPENDENT AND INDEPENDENT DRIVERS OF THERAPEUTIC BENEFIT

Descargar Publicación
The many pathways driving liver inflammation in MASH Científicos descubren una vía que activa la grasa parda